Literature DB >> 33672724

Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.

Claire S Whyte1, Hadj Ahmed Mostefai1, Kim M Baeten1, Andrew J Lucking2, David E Newby2, Nuala A Booth1, Nicola J Mutch1.   

Abstract

The resolution of arterial thrombi is critically dependent on the endogenous fibrinolytic system. Using well-established and complementary whole blood models, we investigated the endogenous fibrinolytic potential of the tissue-type plasminogen activator (tPA) and the intra-thrombus distribution of fibrinolytic proteins, formed ex vivo under shear. tPA was present at physiologically relevant concentrations and fibrinolysis was monitored using an FITC-labelled fibrinogen tracer. Thrombi were formed from anticoagulated blood using a Chandler Loop and from non-anticoagulated blood perfused over specially-prepared porcine aorta strips under low (212 s-1) and high shear (1690 s-1) conditions in a Badimon Chamber. Plasminogen, tPA and plasminogen activator inhibitor-1 (PAI-1) concentrations were measured by ELISA. The tPA-PAI-1 complex was abundant in Chandler model thrombi serum. In contrast, free tPA was evident in the head of thrombi and correlated with fibrinolytic activity. Badimon thrombi formed under high shear conditions were more resistant to fibrinolysis than those formed at low shear. Plasminogen and tPA concentrations were elevated in thrombi formed at low shear, while PAI-1 concentrations were augmented at high shear rates. In conclusion, tPA primarily localises to the thrombus head in a free and active form. Thrombi formed at high shear incorporate less tPA and plasminogen and increased PAI-1, thereby enhancing resistance to degradation.

Entities:  

Keywords:  fibrinolysis; plasminogen activator inhibitor-1; shear; thrombi; tissue plasminogen activator

Mesh:

Substances:

Year:  2021        PMID: 33672724      PMCID: PMC7924342          DOI: 10.3390/ijms22042115

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   6.208


  67 in total

1.  A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity.

Authors:  Timothy J Stalker; John D Welsh; Maurizio Tomaiuolo; Jie Wu; Thomas V Colace; Scott L Diamond; Lawrence F Brass
Journal:  Blood       Date:  2014-06-20       Impact factor: 22.113

2.  Systemic or local thrombolysis in high-risk pulmonary embolism.

Authors:  Liviu Macovei; Razvan Mihai Presura; Catalina Arsenescu Georgescu
Journal:  Cardiol J       Date:  2015-01-07       Impact factor: 2.737

3.  Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.

Authors:  J A van Mourik; D A Lawrence; D J Loskutoff
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

4.  Proteins of the fibrinolytic system in human thrombi.

Authors:  L A Robbie; B Bennett; A M Croll; P A Brown; N A Booth
Journal:  Thromb Haemost       Date:  1996-01       Impact factor: 5.249

5.  TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots.

Authors:  N J Mutch; L Thomas; N R Moore; K M Lisiak; N A Booth
Journal:  J Thromb Haemost       Date:  2007-02-02       Impact factor: 5.824

6.  Characterisation and reproducibility of a human ex vivo model of thrombosis.

Authors:  Andrew J Lucking; Rajesh Chelliah; Alexander D Trotman; Thomas M Connolly; Giora Z Feuerstein; Keith A Fox; Nicholas A Boon; Juan J Badimon; David E Newby
Journal:  Thromb Res       Date:  2010-08-25       Impact factor: 3.944

7.  Plasminogen activator inhibitor (PAI-1) in plasma and platelets.

Authors:  N A Booth; A J Simpson; A Croll; B Bennett; I R MacGregor
Journal:  Br J Haematol       Date:  1988-11       Impact factor: 6.998

8.  Microfluidic Modeling of Thrombolysis.

Authors:  Stéphane Loyau; Benoit Ho-Tin-Noé; Marie-Charlotte Bourrienne; Yacine Boulaftali; Martine Jandrot-Perrus
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

9.  Fibrinolytic response to tumor necrosis factor in healthy subjects.

Authors:  T van der Poll; M Levi; H R Büller; S J van Deventer; J P de Boer; C E Hack; J W ten Cate
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

10.  Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation.

Authors:  Gael B Morrow; Claire S Whyte; Nicola J Mutch
Journal:  Haematologica       Date:  2020-12-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.